Propranolol for Chronic Migraine Prevention
Propranolol is recommended for the prevention of migraine, though it has only a weak recommendation for effectiveness in chronic migraine prevention. 1
Efficacy and Evidence
Propranolol is FDA-approved for migraine prophylaxis 2, with the following characteristics:
- Dosage: 160-240 mg once daily for migraine prevention 2
- Mechanism: Prevents chronic sensitization of descending pain control pathways 3
- Evidence strength: Weak recommendation for migraine prevention according to recent guidelines 1
- Comparative efficacy: Non-inferior to topiramate for chronic migraine prevention 4
Treatment Algorithm for Chronic Migraine Prevention
First-Line Options (Stronger Evidence)
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) - Strong recommendation for both episodic and chronic migraine 1, 5
- OnabotulinumtoxinA - Specifically for chronic migraine 1, 5
- Topiramate - Recommended for both episodic and chronic migraine 1, 6
Second-Line Options (Including Propranolol)
Practical Considerations for Propranolol Use
Dosing
- Starting dose: 80 mg once daily 2
- Titration: Gradually increase dose at 3-7 day intervals 2
- Effective range: 160-240 mg daily for migraine prophylaxis 2
- Lower doses: May be effective in some patients at doses as low as 1 mg/kg/day 7
Monitoring and Expectations
- Allow 2-3 months to assess full efficacy 1, 5
- Use headache diaries to track frequency and severity 5
- Limit acute medications to ≤10 days per month to prevent medication overuse headache 5
Contraindications and Cautions
- Avoid in patients with:
- Asthma
- Diabetes
- Bradycardia
- Congestive heart failure 1
- Common adverse effects:
- Lethargy
- Depression
- Dizziness
- Exercise intolerance
- Hypotension
- Sleep disorders 1
Special Considerations
Risk of Discontinuation
- Gradual tapering is recommended when discontinuing propranolol to avoid rebound effects 1, 2
- Abrupt discontinuation may exacerbate angina and potentially lead to myocardial infarction 1
Medication Interactions
- May increase warfarin bioavailability and prothrombin time 2
- May decrease the AUC of lovastatin or pravastatin by 18-23% 2
When to Consider Alternative Treatments
Consider switching from propranolol to another preventive medication if:
- Inadequate response after 2-3 months of optimal dosing 5
- Intolerable side effects 7
- Presence of contraindications 1
- Patient has comorbidities better addressed by alternative agents (e.g., depression might favor amitriptyline) 1
While propranolol is an established option for migraine prevention, newer agents like CGRP monoclonal antibodies have stronger recommendations specifically for chronic migraine prevention 1, 5.